Memento Medicines Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$93M
- Investors
-
5
Memento Medicines General Information
Description
Developer of antibody-based therapeutics designed to treat retinal and vascular diseases. The company develops bispecific antibody therapies that activate Tie2 signaling and inhibit VEGF pathways, enabling the treatment of conditions such as neovascular age-related macular degeneration and diabetic macular edema.
Contact Information
Corporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Memento Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 18-Jun-2026 | $93M | Completed | Pre-Clinical Trials |
Memento Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 |
Memento Medicines Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avego Management | PE/Buyout | Minority | ||
| Forbion | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| Samsara BioCapital | Venture Capital | Minority | ||
| Sanofi Ventures | Corporate Venture Capital | Minority |
Memento Medicines FAQs
-
When was Memento Medicines founded?
Memento Medicines was founded in 2026.
-
Where is Memento Medicines headquartered?
Memento Medicines is headquartered in Boston, MA.
-
What industry is Memento Medicines in?
Memento Medicines’s primary industry is Drug Discovery.
-
Is Memento Medicines a private or public company?
Memento Medicines is a Private company.
-
What is the current valuation of Memento Medicines?
The current valuation of Memento Medicines is .
-
What is Memento Medicines’s current revenue?
The current revenue for Memento Medicines is .
-
How much funding has Memento Medicines raised over time?
Memento Medicines has raised $93M.
-
Who are Memento Medicines’s investors?
Avego Management, Forbion, RA Capital Management, Samsara BioCapital, and Sanofi Ventures have invested in Memento Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process